We previously showed that NF-κB is stimulated via a BLT2-linked pathway to promote the invasiveness of breast cancer cells [19], and we demonstrated in the present study that LPS-induced NF-κB activation is critical for invasive potential (Fig. 5A). The gene discussed is NFKB1; the disease is breast carcinoma.